Plexus Corp. (NASDAQ:PLXS – Get Free Report) insider Michael Running sold 510 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $272.17, for a total transaction of $138,806.70. Following the sale, the insider owned 665 shares of the company’s stock, valued at approximately $180,993.05. This represents a 43.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Plexus Stock Up 3.4%
Plexus stock opened at $282.29 on Tuesday. The firm has a market cap of $7.55 billion, a PE ratio of 41.27 and a beta of 0.89. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The firm’s 50 day moving average price is $246.76 and its two-hundred day moving average price is $200.76. Plexus Corp. has a twelve month low of $115.35 and a twelve month high of $292.33.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same quarter last year, the business posted $1.66 EPS. The company’s revenue for the quarter was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. On average, research analysts predict that Plexus Corp. will post 5.98 EPS for the current fiscal year.
Institutional Trading of Plexus
Analyst Ratings Changes
Several research analysts have weighed in on the company. Stifel Nicolaus set a $280.00 target price on Plexus in a research report on Tuesday, May 26th. Benchmark reiterated a “buy” rating and set a $220.00 price target on shares of Plexus in a report on Monday, March 16th. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Raymond James Financial restated an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a report on Thursday, April 30th. Finally, Needham & Company LLC raised their price objective on shares of Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Monday, June 1st. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $238.33.
Read Our Latest Analysis on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Plexus
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
